Slide 1Diabetes Management: a Regulatory view Luca Pani [email protected]@aifa.gov.it 10-11 giugno 2013 Slide 2 Public Declaration of transparency/interests* Note: For this…

Slide 1 Keith Tolley, Director, Tolley Health Economics Ltd IDF Europe Symposium 30 th September 2012 1 Tolley Health Economics Ltd Strategic Consulting in Health Economics…

Slide 1 + Diabetes Maureen McQueeney, PharmD, BCPS, BCACP, CDE Slide 2 + Learning Objectives Describe each class of diabetic agents in detail including the following: efficacy,…

Slide 1 New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in…

Slide 1 Controversies in the Management of Patients with Type 2 Diabetes Public Meeting – October 29, 2014 Slide 2 Agenda Meeting Convened | 10am-10:15am –Introduction…

New Approaches Focusing on Dynamic Variables Related to Changes in Memberâs Health Status: Diabetic HbA1c Predictive Model Brenton B. Fargnoli Blue Cross & Blue Shield…

New Approaches Focusing on Dynamic Variables Related to Changes in Memberâs Health Status: Diabetic HbA1c Predictive Model Brenton B. Fargnoli Blue Cross & Blue Shield…

Matthew C. Riddle, Geremia B. Bolli, Monika Ziemen, Isabel Muehlen-Bartmer, Florence Bizet, and Philip D. Home, on behalf of the EDITION 1 Study Investigators Diabetes Care…